These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 6875279)
41. Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility. Fielder AH; Walport MJ; Batchelor JR; Rynes RI; Black CM; Dodi IA; Hughes GR Br Med J (Clin Res Ed); 1983 Feb; 286(6363):425-8. PubMed ID: 6401549 [TBL] [Abstract][Full Text] [Related]
42. Allotypes of the fourth component of complement in Koreans. Park KS; Choi SY; Park MH; Tokunaga K Jpn J Hum Genet; 1992 Dec; 37(4):285-92. PubMed ID: 1297448 [TBL] [Abstract][Full Text] [Related]
43. Partial C4A deficiency is associated with susceptibility to systemic lupus erythematosus in black Americans. Wilson WA; Perez MC; Armatis PE Arthritis Rheum; 1988 Sep; 31(9):1171-5. PubMed ID: 3262348 [TBL] [Abstract][Full Text] [Related]
45. C4 polymorphism: use of a monoclonal antibody to distinguish C4A and C4B locus products. O'Neill GJ Vox Sang; 1984; 47(5):362-5. PubMed ID: 6334403 [TBL] [Abstract][Full Text] [Related]
46. Deletion of complement C4 and steroid 21-hydroxylase genes in the HLA class III region. Carroll MC; Palsdottir A; Belt KT; Porter RR EMBO J; 1985 Oct; 4(10):2547-52. PubMed ID: 2996881 [TBL] [Abstract][Full Text] [Related]
47. An estimate on the frequency of duplicated haplotypes and silent alleles of human C4 protein polymorphism. I. Investigations in healthy Caucasoid families. Steuer M; Mauff G; Adam C; Baur MP; Bender K; Goetz J; Goldmann SF; Hauptmann G; Neugebauer M; Tongio MM Tissue Antigens; 1989 May; 33(5):501-10. PubMed ID: 2799804 [TBL] [Abstract][Full Text] [Related]
48. Genetic polymorphism of the fourth component of complement and type 1 (insulin-dependent) diabetes. Marcelli-Barge A; Poirier JC; Schmid M; Deschamps I; Lestradet H; Prevost P; Hors J Diabetologia; 1984 Jul; 27 Suppl():116-7. PubMed ID: 6332752 [TBL] [Abstract][Full Text] [Related]
49. High resolution electrophoresis for the allotyping of human C4. Proposal of a relational nomenclature. Kölble K; Rukavina V; Kalden JR J Immunol Methods; 1987 Jan; 96(1):69-76. PubMed ID: 3492559 [TBL] [Abstract][Full Text] [Related]
50. DNA polymorphism of human HLA-linked complement C4 allotypes, including C4 null alleles, in the Finnish population. Partanen J; Peltonen L; Koskimies S; Carroll MC Hum Hered; 1987; 37(4):241-9. PubMed ID: 2888726 [TBL] [Abstract][Full Text] [Related]
51. Relative electrophoretic migration distances for the classification of C4 allotypes. Mauff G; Brenden M; Braun-Stilwell M Complement Inflamm; 1990; 7(4-6):277-81. PubMed ID: 2088666 [TBL] [Abstract][Full Text] [Related]
52. Definitive RFLPs to distinguish between the human complement C4A/C4B isotypes and the major Rodgers/Chido determinants: application to the study of C4 null alleles. Yu CY; Campbell RD Immunogenetics; 1987; 25(6):383-90. PubMed ID: 2439447 [TBL] [Abstract][Full Text] [Related]
53. The molecular basis for the difference in immune hemolysis activity of the Chido and Rodgers isotypes of human complement component C4. Isenman DE; Young JR J Immunol; 1984 Jun; 132(6):3019-27. PubMed ID: 6609966 [TBL] [Abstract][Full Text] [Related]
54. Gene and haplotype frequencies of the fourth component of complement (C4) in type 1 diabetics and normal controls. Bertrams J; Hintzen U; Schlicht V; Schoeps S; Gries FA; Louton TK; Baur MP Immunobiology; 1984 May; 166(4-5):335-44. PubMed ID: 6480029 [TBL] [Abstract][Full Text] [Related]
55. Molecular heterogeneity of the fourth component of complement (C4) and its genes in vitiligo. Venneker GT; Westerhof W; de Vries IJ; Drayer NM; Wolthers BG; de Waal LP; Bos JD; Asghar SS J Invest Dermatol; 1992 Dec; 99(6):853-8. PubMed ID: 1469300 [TBL] [Abstract][Full Text] [Related]
56. Identification of two new C4 alleles by DNA sequencing and evidence for a historical recombination of serologically defined C4A and C4B alleles. Hui J; Oka A; Tomizawa M; Tay GK; Kulski JK; Penhale WJ; Iaschi SP; Makino S; Tamiya G; Inoko H Tissue Antigens; 2004 Mar; 63(3):263-9. PubMed ID: 14989717 [TBL] [Abstract][Full Text] [Related]
57. C4 phenotypic variation suggests an unusual class III gene organization. Schendel DJ; Wank R; O'Neill GJ Vox Sang; 1985; 48(2):110-5. PubMed ID: 3878038 [TBL] [Abstract][Full Text] [Related]
58. Deficiency of C4A is a genetic determinant of systemic lupus erythematosus in three ethnic groups. Dunckley H; Gatenby PA; Hawkins B; Naito S; Serjeantson SW J Immunogenet; 1987; 14(4-5):209-18. PubMed ID: 3502648 [TBL] [Abstract][Full Text] [Related]
59. Hydralazine binds covalently to complement component C4. Different reactivity of C4A and C4B gene products. Sim E; Law SK FEBS Lett; 1985 May; 184(2):323-7. PubMed ID: 3873356 [TBL] [Abstract][Full Text] [Related]
60. The polymorphism of the complement genes in HLA. Porter RR Ann Inst Pasteur Immunol (1985); 1985; 136C(1):91-101. PubMed ID: 3873205 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]